List of biotechnology companies

From Wikipedia, the free encyclopedia
Jump to: navigation, search

A biotechnology company is a company whose products or services primarily use biotechnology methods for their production, design or delivery. The United Nations Convention on Biological Diversity defines 'biotechnology' as: "Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use."[1] In other words, biotechology can be defined as the mere application of technical advances in life science to develop commercial products. Today, no comprehensive global database of biotech companies is available online, despite the fact that a free and open access project was launched in late 2014.[2]

Independent biotechnology companies[edit]

  • The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization as of June 2015 (Q2 2015).
  • Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups - such as Genentech (owned by Roche), Genzyme (Sanofi), or MedImmune (AstraZeneca).
Rank Change Company Country Highest Market Cap ever (historical)(USD billions) Market Cap in Q2 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Steady Johnson & Johnson USA 306.4
September 2014
276.9 277.8 258.3
2 Increase Novartis SUI 275.2
July 2015
272.6 229.8 195.0
3 Decrease Roche SUI 263.6
February 2014
240.4 258.5 240.3
4 Steady Pfizer USA 310.5
July 2000
211.7 205.4 196.0
5 Steady Merck USA 178.9
January 2015
162.3 166.9 146.5
6 Increase Novo Nordisk DEN 153.8
June 2015
147.0 125.4 19.6
7 Decrease Gilead Sciences USA 179.6
June 2013
145.1 109.0 78.4
8 Decrease Sanofi FRA 151.3
September 2014
136.0 138.1 142.0
9 Decrease Amgen USA 130.6
December 2014
117.7 93.1 78.7
10 Increase Allergan USA 122.6
July 2015
116.7 38.2 15.0
11 Decrease GlaxoSmithKline GBR 174.9
May 2006
114.1 128.9 129.6
12 Decrease Bayer GBR 129
March 2015
111.2 113.2 117.4
13 Steady Bristol-Myers Squibb USA 115.3
May 2015
105.0 97.6 87.2
14 Steady Biogen Idec USA 111.7
March 2015
97.0 79.7 66.1
15 Steady AbbVie USA 112.2
June 2015
91.7 104.1 83.8
16 Steady Celgene USA 102.9
March 2015
90.4 89.5 69.2
17 Steady AstraZeneca GBR 102.9
October 2006
87.7 88.9 74.6
18 Steady Eli Lilly & Co USA 122.6
August 2000
79.2 76.6 57.0
19 Steady Abbott Laboratories USA 74.8
July 2015
69.9 67.9 59.3
20 Steady Valeant Pharmaceuticals CAN 82.8
May 2015
67.7 47.9 39.1
21 Steady Teva Pharmaceutical ISR 58.9
April 2010
54.5 49.0 37.8
22 Steady Regeneron Pharmaceuticals Inc USA 55.7
June 2015
54.3 42.0 27.4
23 Steady Shire Pharmaceuticals IRL 52.4
October 2014
49.8 42.4 28.1
24 Steady Alexion Pharmaceuticals USA 43.1
June 2015
43.5 36.8 26.2
25 Steady Mylan NED 37.2
April 2015
34.9 21.2 16.1

References[edit]

External links[edit]